title: Type of post-grafting immunosuppression after non-myeloablative blood cell transplantation may influence risk of delayed haemolysis due to minor ABO incompatibility.
authors.forename: Marco
authors.initials: M
authors.lastname: Mielcarek
authors.forename: J Maciej
authors.initials: JM
authors.lastname: Zaucha
authors.forename: Brenda
authors.initials: B
authors.lastname: Sandmaier
authors.forename: David
authors.initials: D
authors.lastname: Maloney
authors.forename: James
authors.initials: J
authors.lastname: Butrynski
authors.forename: Michael
authors.initials: M
authors.lastname: Maris
authors.forename: Lyle
authors.initials: L
authors.lastname: Feinstein
authors.forename: Beverly
authors.initials: B
authors.lastname: Torok-Storb
authors.forename: Rainer
authors.initials: R
authors.lastname: Storb
mesh_terms: D000328:Adult; D001787:Blood Group Incompatibility; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods* / Q000401:mortality; D006461:Hemolysis; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000628:therapy; D008297:Male; D008875:Middle Aged
chemical_list: D007166:Immunosuppressive Agents